Annotated Medicine and Device Lists
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| Gelusil | Tablet (chewable) | N/A | |
| magnesium trisilicate | mixture | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| aluminum hydroxide + magnesium trisilicate | Suspension | 250 ml | |
| aluminum hydroxide + magnesium trisilicate | Suspension | 500 ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| Dicyclomine | Capsule | 10 mg | |
| Dicyclomine | Syrup | 10 mg/ 5ml | |
| domperidone | Tablet | 10 mg | |
| hyoscine butylbromide | Injection | 20 mg in 1-mL ampoule | |
| hyoscine butylbromide | Tablet | 10mg | |
| Mebeverine | Tablet | 135 mg | |
| metoclopramide | Injection | 5 mg (hydrochloride)/mL in 2-mL ampoule | |
| metoclopramide | Syrup | 5 mg/5 ml | |
| metoclopramide | Tablet | 10mg | |
| peppermint oil | Capsule | N/A | |
| peppermint oil | drops | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ranitidine | Injection | 25 mg/mL (as hydrochloride) in 2-mL ampoule | |
| ranitidine | Syrup | 150 mg/ 10 ml | |
| ranitidine | Tablet | 150 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| Lansoprazole | Capsule | 30 mg | |
| Lansoprazole | Tablet | 15 mg | |
| Lansoprazole | Tablet (dispersible) | 30 mg | |
| omeprazole | Capsule | 20 mg | |
| omeprazole | Injection | 40 mg/ ml | |
| pantoprazole | Injection | 40 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| Diphenoxylate + Atropine | Tablet | 2.5 + 0.025 mg | |
| loperamide | Tablet | 2 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| mesalazine | Tablet | 400 mg | |
| prednisolone | Tablet | 1 mg. | |
| prednisolone | Tablet | 20 mg | |
| prednisolone | Tablet | 5 mg | |
| sulfasalazine | Tablet | 500 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| Ispaghula husk | Powder | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| bisacodyl | Suppository | 10 mg | |
| bisacodyl | Tablet | 5 mg | |
| docusate sodium | Capsule | 100 mg | |
| docusate sodium | Syrup | 4 mg/ml | |
| glycerine | Suppository | - Paediatric | |
| glycerine | Suppository | -Adult | |
| senna | Tablet | 7.5 mg (sennosides) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| paraffin | Oral solution | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| lactulose | Syrup | N/A | |
| phosphates | enema | adult | |
| phosphates | enema | pediatric |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| Klean-Prep | Sachet | N/A | |
| Magnesium Citrate | mixture | N/A | |
| Sodium Picosulphate and Magnesium Citrate | Oral powder | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| Haemorrhoidal | Ointment | N/A | |
| Haemorrhoidal | Suppository | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| Ultraproct | Ointment | (1g contains Flucortolone Pivalate 0.92mg, Flucortolone Hexanoate 0.95mg, Cinchocaine Hydrochloride 5mg) | |
| Ultraproct | Suppository | ( Flucortolone Pivalate 0.63mg, Flucortolone Hexanoate 0.610mg, Cinchocaine Hydrochloride 1mg) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| oily phenol | Injection | 5% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| diltiazem | Cream | 2 % |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ursodeoxycholic acid | Tablet | 150 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| colestiramina | Sachet | 4 g |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| pancreatin | Capsule | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| chlorthalidone | Tablet | 50 mg | |
| hydrochlorothiazide | Tablet | 25 mg | |
| hydrochlorothiazide | Tablet | 50 mg | |
| metolazone | Tablet | 5 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| furosemide | Injection | 10 mg/ml | |
| furosemide | Injection | 10 mg/mL in 2-mL ampoule | |
| furosemide | Tablet | 40 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| spironolactone | Tablet | 25 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| hydrochlorthiazide + triamterene | Tablet | 25 mg/ 50 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| mannitol | Parenteral solution | 20% (500 ml) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| adenosine | Injection | 3 mg/mL in 2-mL ampoule | |
| amiodarone | Injection | 50 mg/ml | |
| amiodarone | Tablet | 200 mg | |
| Disopyramide Phosphate | Injection | 10 mg/ml | |
| flecainide | Injection | 10 mg/ml | |
| lidocaine | Injection | 100 mg/ml | |
| lidocaine | Solution for injection | 100 mg/ 5 ml | |
| Mexiletine | Capsule | 200 mg | |
| phenytoin | Injection | 50 mg/mL | |
| propafenone | Tablet | 150 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| atenolol | Injection | 500 mcg/ml | |
| atenolol | Tablet | 100 mg | |
| atenolol | Tablet | 25 mg | |
| atenolol | Tablet | 50 mg | |
| carvedilol | Tablet | 25 mg | |
| carvedilol | Tablet | 6.25 mg | |
| esmolol | Injection | 10 mg/ml | |
| labetalol | Injection | 5mg/ml | |
| labetalol | Tablet | 100 mg | |
| metoprolol | Injection | 1 mg/ml | |
| metoprolol | Tablet | 25 mg | |
| metoprolol | Tablet | 50 mg | |
| Nadolol | Tablet | 40 mg | |
| Nadolol | Tablet | 80 mg | |
| propranolol | Injection | 1 mg/ ml | |
| propranolol | Tablet | 10 mg | |
| propranolol | Tablet | 20 mg | |
| propranolol | Tablet | 40mg | |
| propranolol | Tablet | 80mg | |
| sotalol | Tablet | 80 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| hydralazine | Solution for injection | 10 mg/ ml | |
| hydralazine | Tablet | 25 mg | |
| minoxidil | Tablet | 10 mg | |
| minoxidil | Tablet | 2.5 mg | |
| sodium nitroprusside | Injection | 10 mg/mL/5 mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| clonidine | Patch | 0.1 mg | |
| clonidine | Patch | 0.3 mg | |
| methyldopa | Tablet | 250 mg | |
| methyldopa | Tablet | 500mg | |
| Moxonidine | Tablet | 20 mcg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| captopril | Tablet | 25 mg | |
| captopril | Tablet | 50 mg | |
| enalapril | Tablet | 10 mg | |
| enalapril | Tablet | 5 mg | |
| lisinopril | Tablet | 20 mg | |
| lisinopril | Tablet | 5 mg | |
| ramipril | Tablet | 2.5 mg | |
| ramipril | Tablet | 5 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| candesartan cilexetil | Tablet | 16 mg | |
| candesartan cilexetil | Tablet | 8 mg | |
| losartan | Tablet | 100 mg | |
| losartan | Tablet | 25 mg | |
| losartan | Tablet | 50mg | |
| valsartan | Tablet | 160 mg | |
| valsartan | Tablet | 80 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| glycerine trinitrate | Tablet (sublingual) | 400 mcg | |
| glyceryl trinitrate | Patch | 10 mg | |
| glyceryl trinitrate | Patch | 5 mg | |
| glyceryl trinitrate | spray | 0.4 mg | |
| isosorbide dinitrate | Tablet | 40 mg | |
| isosorbide mononitrate | Tablet | 40 mg | |
| nitroglycerine | Injection | 100 microgram/ml (in Dextrose/5% Water) -500ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amlodipine | Tablet | 10 mg | |
| amlodipine | Tablet | 5 mg | |
| diltiazem | Tablet | 60 mg | |
| diltiazem | Tablet (controlled release) | 120 mg | |
| diltiazem | Tablet (prolonged release) | 180 mg | |
| nifedipine | Tablet (controlled release) | 20mg | |
| nimodipine | Injection | 0.2 mg/mL | |
| nimodipine | Tablet | 30 mg. | |
| verapamil | Injection | 2.5 mg/mL | |
| verapamil | Tablet | 240 mg (hydrochloride) | |
| verapamil | Tablet | 40 mg | |
| verapamil | Tablet | 80 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| Nicorandil | Tablet | 10 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| cilostazol | Tablet | 100 mg | |
| pentoxifylline | Tablet | 400 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| dobutamine | Injection | 12.5mg (hydrochloride)/mL in 20 ml vial | |
| dopamine | Injection | 40 mg/mL (hydrochloride) in 5-mL vial | |
| dopamine | Injection | 800 mg/250ml (in Dextrose/5% Water) , | |
| isoprenaline | Injection | 1 / 50,000- 10 ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ephedrine | Injection | 25 mg/ml | |
| norepinephrine | Solution for injection | 2 mg/ ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| epinephrine (adrenaline) | Injection | 0.01% (1: 10000) | |
| epinephrine (adrenaline) | Injection | 0.1% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| dalteparin | Injection | 25,000 IU (sodium)/ml | |
| dalteparin | Injection | 2500 IU/0.2mL | |
| enoxaparin | Injection | 100 mg/ 1 mL | |
| enoxaparin | Injection | 20 mg/ 0.2 mL | |
| enoxaparin | Injection | 40 mg/ 0.4 ml | |
| enoxaparin | Injection | 60 mg/ 0.6 ml | |
| enoxaparin | Injection | 80 mg/ 0.8 mL | |
| heparin sodium | Injection | 10000 u/ml | |
| heparin sodium | Injection | 10000 u/ml | |
| heparin sodium | Injection | 5000 IU/mL in 1-mL ampoule | |
| heparin sodium | Injection | 5000 IU/mL in 5-mL vial |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| protamine sulfate | Injection | 10 mg/mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetylsalicylic acid | Tablet | 300 mg | |
| acetylsalicylic acid | Tablet | 325 mg | |
| acetylsalicylic acid | Tablet (chewable) | 81 mg | |
| acetylsalicylic acid | Tablet (dispersible) | 75 mg | |
| clopidogrel | Tablet | 75 mg | |
| dipyridamole | Tablet (controlled release) | 200 mg | |
| dipyridamole | Tablet (controlled release) | 50 mg | |
| Dipyridamole + acetylsalicylic acid | Tablet | 200 mg + 25 mg | |
| tirofiban | Infusion | 50 mcg/ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| alteplase | Injection | 1 mg/ml | |
| streptokinase | Powder for injection | 1.5 million IU in vial | |
| tenecteplase | Injection | 5 mg/ml | |
| Urokinase | Injection | 10,000 Units |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| factor IX | Injection | N/A | |
| factor VIII | Injection | N/A | |
| tranexamic acid | Injection | 100 mg/ml | |
| tranexamic acid | Tablet | 500 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| atorvastatine | Tablet | 10 mg | |
| atorvastatine | Tablet | 20 mg | |
| atorvastatine | Tablet | 40 mg | |
| cholestyramine | Powder for oral administration | 4-g sachet | |
| ezetimiba | Tablet | 10 mg | |
| fenofibrato | Capsule | 200 mg | |
| gemfibrozil | Tablet | 600mg | |
| lovastatin | Tablet | 20mg | |
| pravastatin | Tablet | 20mg | |
| pravastatin | Tablet | 40 mg | |
| simvastatin | Tablet | 20 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| Sodium tetradecyl sulfate | Injection | 0.2 % | |
| Sodium tetradecyl sulfate | Injection | 0.5 % | |
| Sodium tetradecyl sulfate | Injection | 3 % |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| salbutamol | Inhalation | 100 mcg/metered dose | |
| salbutamol | Injection | 0.5 mg/mL | |
| salbutamol | Injection | 1 mg/ mL - 5 mL | |
| salbutamol | Oral liquid | 2 mg/5 mL | |
| salbutamol | respirator solution for use in nebulizers | 0.5% | |
| salbutamol | Tablet | 4 mg | |
| salmeterol | Inhalation | 25microgram per metered dose inhaler |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| epinephrine (adrenaline) | Injection | 0.01% (1: 10000) | |
| epinephrine (adrenaline) | Injection | 0.1% | |
| Racepinephrine | Solution for inhalation | 2.25% solution |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ipratropium bromide | Inhalation (aerosol) | 20 micrograms/metered dose | |
| ipratropium bromide | Solution | 250 mcg/ ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| aminophylline | Injection | 25 mg/mL | |
| theophylline | Syrup | 60 mg/ 5 ml | |
| theophylline | Tablet | 250 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ipratropium bromide + salbutamol | Inhalation | 20 + 100mcg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| Peak Flow Meters | N/A | N/A | |
| Peak Flow Meters | N/A | (pocket size) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| beclometasone | Inhalation (aerosol) | 250 micrograms (dipropionate) per dose | |
| beclometasone | Metered dose inhaler (aerosol) | 50 micrograms (dipropionate) per dose | |
| budesonide | Nasal spray | 250 micrograms per dose | |
| fluticasone | Metered dose inhaler (aerosol) | 125 mcg | |
| fluticasone | Metered dose inhaler (aerosol) | 250 mcg | |
| fluticasone | Metered dose inhaler (aerosol) | 50 mcg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| sodium cromoglicate | Metered dose inhaler (aerosol) | 5 mg | |
| sodium cromoglicate | respirator solution for use in nebulizers | 10 mg/ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| montelukast | Tablet | 10 mg | |
| montelukast | Tablet (chewable) | 4 mg | |
| montelukast | Tablet (chewable) | 5 mg | |
| zafirlukast | Tablet | 20 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| cetirizine | Oral liquid | 5mg/5ml | |
| cetirizine | Tablet | 10 mg | |
| chlorpheniramine | Injection | 10 mg/mL (IM,IV) | |
| chlorpheniramine | Syrup | 2 mg/ 5ml | |
| chlorpheniramine | Tablet | 4 mg | |
| clemastine | Tablet | 1 mg | |
| cyproheptadine | Syrup | 2 mg/ 5ml | |
| cyproheptadine | Tablet | 4 mg | |
| diphenhydramine | Capsule | 25 mg | |
| diphenhydramine | Injection | 50 mg/mL | |
| diphenhydramine | Oral liquid | 12.5 mg/5 mL | |
| hydroxyzine | Capsule | 25 mg | |
| hydroxyzine | Oral suspension | 10 mg/ 5 ml | |
| ketotifen | Oral liquid | 1mg/5ml | |
| ketotifen | Tablet | 1 mg | |
| loratadine | Tablet | 10 mg | |
| promethazine | Injection | 25mg (hydrochloride)/ml | |
| promethazine | Syrup | 5 mg/ 5ml | |
| promethazine | Tablet | 10 mg | |
| promethazine | Tablet | 25 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| allergenic extract | N/A | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| epinephrine (adrenaline) | Injection | 0.1% | |
| epinephrine (adrenaline) | Injection | 1:2000 |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| doxapram | Injection | 20 mg/ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| beractant | Suspension | 25 mg/ml | |
| surfactant | N/A | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetylcysteine | Injection | 200 mg/ml in 10-ml ampoule |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| Aromatic Ammonia Spirit | N/A | N/A | |
| benzoin | tincture | N/A | |
| menthol crystals | N/A | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| codeine | Oral solution | 15 mg/ 5 ml | |
| Pholcodeine | Oral liquid | 5 mg/ 5ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| Guaifenesin | Syrup | 100 mg/ 5ml | |
| Simple linctus | N/A | (sugar free) | |
| Simple linctus | N/A | Paediatric (sugar free) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| Chlorpheniramine /Phenylephrine /Dextromethorphan | drops | 1 mg + 3.5mg + 3mg/ml | |
| pseudoephedrine | Oral liquid | 6 mg/mL | |
| pseudoephedrine | Tablet | 60 mg | |
| Pseudoephedrine /Triprolidine | Syrup | 30 mg + 12.5mg | |
| Pseudoephedrine /Triprolidine | Tablet | 60 mg + 2.5mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| cafeine citrate | Oral solution | 20 mg/ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| chloral hydrate | Oral liquid | 500 mg/5 mL | |
| promethazine | Injection | 25mg (hydrochloride)/ml | |
| promethazine | Syrup | 5 mg/ 5ml | |
| promethazine | Tablet | 10 mg | |
| promethazine | Tablet | 25 mg | |
| Temazepam | Syrup | 10 mg/ 5ml | |
| Temazepam | Tablet | 10 mg | |
| zopiclone | Tablet | 3.75 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| aripiprazole | Tablet | 10 mg | |
| chlorpromazine | Injection | 25 mg/ ml | |
| chlorpromazine | Syrup | 25 mg/ 5 ml | |
| chlorpromazine | Tablet | 100 mg | |
| chlorpromazine | Tablet | 25 mg | |
| haloperidol | Injection | 5 mg/mL | |
| haloperidol | Oral liquid | 2 mg/mL | |
| haloperidol | Tablet | 1 mg | |
| haloperidol | Tablet | 5 mg | |
| levomepromazine | Injection | 25 mg/ ml | |
| olanzapine | Tablet | 5 mg | |
| prochlorperazine | Injection | 12.5 mg/ml x 1 ml | |
| quetiapine | Tablet | 100 mg | |
| quetiapine | Tablet | 50 mg | |
| risperidone | Solution | 1 mg/ml | |
| risperidone | Tablet | 1mg | |
| risperidone | Tablet | 3mg | |
| risperidone | Tablet (dispersible) | 1 mg | |
| risperidone | Tablet (dispersible) | 2 mg | |
| thioridazine | Tablet | 10 mg | |
| thioridazine | Tablet | 25 mg | |
| thioridazine | Tablet | 50 mg | |
| trifluoperazine | Tablet | 1 mg | |
| trifluoperazine | Tablet | 2 mg | |
| trifluoperazine | Tablet | 5 mg | |
| zuclopenthixol acetate acuphase | Injection | 50 mg/ml | |
| zuclopenthixol dehydrochloride | drops | 20 mg/ml | |
| zuclopenthixol dehydrochloride | Tablet | 10 mg | |
| zuclopenthixol dehydrochloride | Tablet | 2 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| flupenthixol decanoate | Injection | 100 mg/ml | |
| fluphenazine | Injection | 25 mg/ ml x 1 ml | |
| haloperidol | Injection | 50 mg/ml | |
| risperidone | Injection | 25 mg | |
| risperidone | Injection | 37.5 mg | |
| zuclopenthixol decanoate depot | Injection | 200 mg/ml | |
| zuclopenthixol decanoate depot | Injection | 500 mg/ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| lithium carbonate | Tablet | 250 mg | |
| lithium carbonate | Tablet | 500 mg | |
| valproic acid (sodium valproate) | Tablet | 250 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amitriptyline | Tablet | 10 mg | |
| amitriptyline | Tablet | 25 mg | |
| amitriptyline | Tablet | 50 mg | |
| clomipramine | Tablet | 25 mg | |
| Desipramine | Tablet | 25 mg | |
| Dosulepin | Capsule | 25 mg | |
| Dosulepin | Capsule | 75 mg | |
| Doxepin | Capsule | 25 mg | |
| imipramine | Tablet | 10 mg | |
| imipramine | Tablet | 25 mg | |
| imipramine | Tablet | 50 mg | |
| trazodone | Tablet | 50 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| citalopram | Tablet | 20 mg | |
| fluoxetine | Capsule | 20 mg | |
| fluoxetine | Oral liquid | 20 mg/5 ml | |
| paroxetine | Tablet | 20 mg | |
| sertraline | Capsule | 100 mg | |
| sertraline | Capsule | 50 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| bupropiona clorhidrato | Tablet (controlled release) | 150 mg | |
| duloxetine | Capsule | 30 mg | |
| liothyronine | Tablet | 25mcg | |
| mirtazapine | Tablet | 15 mg | |
| mirtazapine | Tablet | 30mg | |
| venlafaxine | Tablet | 75 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| Dextroamphetamine Saccharate | Tablet | 10 mg | |
| Dextroamphetamine Saccharate | Tablet | 15 mg | |
| Dextroamphetamine Saccharate | Tablet | 30 mg | |
| methylphenidate | Tablet | 18 mg | |
| methylphenidate | Tablet | 27 mg | |
| methylphenidate | Tablet | 36 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| aprepitant | Capsule | 3-day pack of one 123mg | |
| aprepitant | Capsule | 80mg | |
| chlorpromazine | Injection | 25 mg/ ml | |
| chlorpromazine | Syrup | 25 mg/ 5 ml | |
| chlorpromazine | Tablet | 100 mg | |
| chlorpromazine | Tablet | 25 mg | |
| cinnarizine | Tablet | 15 mg | |
| dimenhydrinate | Injection | 50 mg/mL | |
| dimenhydrinate | Suppository | 25 mg | |
| dimenhydrinate | Syrup | 15 mg/5 ml | |
| dimenhydrinate | Tablet | 50 mg | |
| diphenhydramine | Capsule | 25 mg | |
| diphenhydramine | Injection | 50 mg/mL | |
| diphenhydramine | Oral liquid | 12.5 mg/5 mL | |
| domperidone | Tablet | 10 mg | |
| granisetron | Injection | 1 mg/ml | |
| granisetron | Tablet | 2 mg | |
| hyoscine hydrobromide | Patch | 1 mg/72 hours | |
| metoclopramide | Injection | 5 mg/ml (hydrochloride) | |
| metoclopramide | Oral liquid | 5 mg/5 mL | |
| metoclopramide | Tablet | 10mg | |
| ondansetron | Injection | 2 mg/ml | |
| ondansetron | Tablet | 4 mg | |
| prochlorperazine | Injection | 12.5 mg/ml x 1 ml | |
| prochlorperazine | Suppository | 25 mg | |
| prochlorperazine | Tablet | 5 mg | |
| promethazine | Injection | 25mg (hydrochloride)/ml | |
| promethazine | Syrup | 5 mg/ 5ml | |
| promethazine | Tablet | 10 mg | |
| promethazine | Tablet | 25 mg | |
| trifluoperazine | Tablet | 1 mg | |
| trifluoperazine | Tablet | 2 mg | |
| trifluoperazine | Tablet | 5 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetaminofen | Suppository | 120 mg | |
| acetaminofen | Suppository | 650 mg | |
| acetaminofen | Syrup | 120 mg/ 5ml | |
| acetaminofen | Tablet | 500 mg | |
| acetylsalicylic acid | Tablet | 325 mg | |
| acetylsalicylic acid | Tablet | 325 mg | |
| acetylsalicylic acid | Tablet | 75 mg | |
| paracetamol + codeine | Tablet | 500 mg + 10mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| buprenorfina | Tablet (sublingual) | 200 mcg | |
| Diamorphine | Injection | 10 mg | |
| Diamorphine | Injection | 10 mg | |
| Diamorphine | Injection | 30 mg | |
| dihydrocodeine | Tablet | 30 mg | |
| fentanyl | Patch | 100 mcg/hr | |
| fentanyl | Patch | 25 mcg/hr | |
| fentanyl | Patch | 50 mcg/hr | |
| morphine | Oral liquid | 10 mg/5 ml | |
| morphine | Oral solution | 100 mg/5 ml | |
| morphine | Tablet (controlled release) | 10 mg | |
| morphine | Tablet (controlled release) | 30 mg | |
| morphine sulfate | Tablet (controlled release) | 100 mg | |
| nalbuphine hydrochloride | Solution for injection | 10 mg/ml | |
| pethidine | Injection | 50 mg/ml | |
| pethidine | Injection | 50 mg/ml x 2 ml | |
| pethidine | Tablet | 50 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amitriptyline | Tablet | 10 mg | |
| amitriptyline | Tablet | 25 mg | |
| amitriptyline | Tablet | 50 mg | |
| carbamazepine | Oral liquid | 100 mg/5 ml | |
| carbamazepine | Tablet | 200 mg | |
| carbamazepine | Tablet | 400mg | |
| duloxetine | Capsule | 30 mg | |
| gabapentin | Capsule | 100 mg | |
| gabapentin | Capsule | 300 mg. | |
| pregabalin | Capsule | 75 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| dihydroergotamine mesylate | Injection | 1 mg/mL in ampoule | |
| ergotamine + caffeine | Tablet | 1 mg (tartrate) + 100 mg | |
| naratriptan | Tablet | 2,5 mg | |
| sumatriptan | Injection | 12 mg/mL | |
| sumatriptan | Tablet | 50 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| clonidine | Tablet | 0.1 mg | |
| cyproheptadine | Syrup | 2 mg/ 5ml | |
| cyproheptadine | Tablet | 4 mg | |
| Pizotifen | Tablet | 0.5 mg | |
| Pizotifen | Tablet | 1.5 mg | |
| propranolol | Tablet | 10 mg | |
| propranolol | Tablet | 20 mg | |
| propranolol | Tablet | 40mg | |
| topiramate | Tablet | 100 mg | |
| topiramate | Tablet | 200 mg | |
| topiramate | Tablet | 25 mg | |
| topiramate | Tablet | 50 mg | |
| valproic acid (sodium valproate) | Oral liquid | 200 mg/5 ml | |
| valproic acid (sodium valproate) | Tablet | 250 mg | |
| valproic acid (sodium valproate) | Tablet (enteric-coated) | 200 mg (sodium valproate) | |
| valproic acid (sodium valproate) | Tablet (enteric-coated) | 500 mg (sodium valproate) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| carbamazepine | Oral liquid | 100 mg/5 ml | |
| carbamazepine | Tablet (controlled release) | 200 mg | |
| carbamazepine | Tablet (controlled release) | 400 mg | |
| clonazepam | Tablet | 2mg | |
| ethosuximide | Capsule | 250 mg | |
| ethosuximide | Oral liquid | 250 mg/5 ml | |
| gabapentin | Capsule | 100 mg | |
| gabapentin | Capsule | 300 mg. | |
| lamotrigine | Tablet | 100 mg | |
| lamotrigine | Tablet | 25 mg | |
| levetiracetam | Tablet | 500 mg | |
| phenobarbital | Injection | 30m mg/ml | |
| phenobarbital | Oral liquid | 15 mg/5 mL | |
| phenobarbital | Tablet | 15 mg to 100 mg | |
| phenobarbital | Tablet | 30 mg | |
| phenytoin | Capsule | 100 mg | |
| phenytoin | Capsule | 300 mg | |
| phenytoin | Injection | 50 mg/mL | |
| phenytoin | Oral liquid | 25 mg/ 5 mL | |
| pregabalin | Capsule | 75 mg | |
| primidone | Tablet | 250 mg | |
| topiramate | Tablet | 100 mg | |
| topiramate | Tablet | 200 mg | |
| topiramate | Tablet | 25 mg | |
| topiramate | Tablet | 50 mg | |
| valproic acid (sodium valproate) | Oral liquid | 200 mg/5 ml | |
| valproic acid (sodium valproate) | Tablet | 250 mg | |
| valproic acid (sodium valproate) | Tablet (enteric-coated) | 200 mg (sodium valproate) | |
| valproic acid (sodium valproate) | Tablet (enteric-coated) | 500 mg (sodium valproate) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| bromocriptine mesylate | Tablet | 2.5 mg | |
| cabergoline | Tablet | 500 mcg | |
| levodopa + carbidopa | Tablet | 100 mg/ 25 mg | |
| levodopa + carbidopa | Tablet | 100 mg/ 25 mg | |
| levodopa + carbidopa | Tablet | 250 mg + 25 mg | |
| Ropinrole | Tablet | 1 mg | |
| Ropinrole | Tablet | 250 mcg | |
| selegiline | Tablet | 5mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| benztropine mesylat | Injection | 1 mg/ml x 2 ml | |
| benztropine mesylat | Tablet | 2 mg | |
| orfenadrine | Injection | 30mg (citrate)/ml in 2ml vial | |
| orfenadrine | Tablet | 50 mg | |
| procyclidine | Injection | 5 mg/mL in ampoule | |
| procyclidine | Syrup | 5 mg/ml | |
| procyclidine | Tablet | 5 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| haloperidol | Tablet | 1 mg | |
| haloperidol | Tablet | 5 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| buprenorfina | Tablet (sublingual) | 200 mcg | |
| bupropiona clorhidrato | Tablet (prolonged release) | 150 mg | |
| chlordiazepoxide | Capsule | 5 mg | |
| naltrexone | Tablet | 50 mg (hydrochloride) | |
| nicotine replacement therapy (NRT) | Transdermal patches | 14 mg | |
| nicotine replacement therapy (NRT) | Transdermal patches | 21 mg | |
| nicotine replacement therapy (NRT) | Transdermal patches | 7 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| donepezil hcl | Tablet | 10 mg | |
| donepezil hcl | Tablet | 5 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amoxicillin | Capsule | 250 mg | |
| amoxicillin | Capsule | 500 mg | |
| amoxicillin | Injection | 250 mg | |
| amoxicillin | Injection | 500 mg | |
| amoxicillin | Oral liquid | 250 mg/5 mL | |
| amoxicillin | Sachet | 3 g | |
| amoxicillin | Suspension | 125 mg/ 5 ml | |
| amoxicillin + clavulanic acid | Injection | 500 mg/100 mg | |
| amoxicillin + clavulanic acid | Powder for injection | 1g + 0.2g | |
| amoxicillin + clavulanic acid | Suspension | 228 mg/ 5ml | |
| amoxicillin + clavulanic acid | Suspension | 457 mg/5 ml | |
| amoxicillin + clavulanic acid | Suspension | 642.9 mg/5 mL | |
| amoxicillin + clavulanic acid | Tablet | 500 mg (as trihydrate) + 125 mg (as potassium salt) | |
| amoxicillin + clavulanic acid | Tablet | 875mg + 125mg | |
| benzathine benzylpenicillin | Powder for injection | 1.44 g benzylpenicillin (= 2.4 million IU) in 5-ml vial | |
| benzathine benzylpenicillin | Powder for injection | 900 mg benzylpenicillin (= 1.2 million IU) in 5-ml vial | |
| flucloxacillin | Capsule | 500 mg | |
| flucloxacillin | Oral liquid | 125 mg/5 mL (sodium salt) | |
| flucloxacillin | Oral liquid | 250mg/5ml (sodium salt) | |
| flucloxacillin | Powder for injection | 500 mg | |
| phenoxymethylpenicillin | Suspension | 125 mg/5 mL | |
| phenoxymethylpenicillin | Suspension | 250 mg/5mL | |
| phenoxymethylpenicillin | Tablet | 250 mg | |
| piperacillin sodium + tazobactum sodium | Solution for injection | 4 g/ 500 mg | |
| procaine penicillin | Injection | 1.2 million unit |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| cefadroxil | Oral liquid | 250mg/5ml | |
| cefalexin | Oral liquid | 125 mg/5 mL | |
| cefalexin | Oral liquid | 250 mg/5 mL | |
| cefalexin | Tablet | 250 mg | |
| cefalexin | Tablet | 500 mg | |
| cefazolin | Injection | 1g | |
| cefotaxime | Powder for injection | 500 mg | |
| ceftazidime | Injection | 1 g | |
| ceftriaxone | Injection | 1 g | |
| cefuroxime | Injection | 750 mg | |
| cefuroxime | Suspension | 125 mg/5 ml | |
| cefuroxime | Tablet | 250 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| doxycycline | Capsule | 100 mg | |
| minocycline | Capsule | 50 mg | |
| tetracycline | Capsule | 250 mg | |
| tetracycline | Injection | 500 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| gentamicin | Injection | 10 mg/ml | |
| gentamicin | Injection | 40 mg/ml | |
| neomycin | Tablet | 500mg (sulfate) | |
| tobramycin | Injection | 40 mg/mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| azithromycin | Suspension | 200 mg/5 ml | |
| azithromycin | Tablet | 500 mg | |
| clarithromycin | Suspension | 250 mg/5 ml | |
| clarithromycin | Tablet | 500 mg | |
| erythromycin | Injection | -Lactobionate 1 gram | |
| erythromycin | Oral suspension | 125 mg/5 mL (ethylsuccinate) | |
| erythromycin | Suspension | 250 mg (ethysuccinate)/5 mL | |
| erythromycin | Tablet | 250 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| clindamycin | Capsule | 150 mg | |
| clindamycin | Injection | 150 mg/mL | |
| clindamycin | Suspension | 75 mg/5mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| chloramphenicol | Capsule | 250 mg | |
| chloramphenicol | Injection | 100 mg/ml | |
| meropenem | Injection | 1g | |
| meropenem | Injection | 500 mg | |
| sodium fusidate | Injection | 500 mg | |
| sodium fusidate | Suspension | 250 mg/ 5ml | |
| sodium fusidate | Tablet | 250 mg | |
| spectinomycin | Powder for injection | 2 g (as hydrochloride) in vial | |
| teicoplanin | Injection | 200 mg in ampoule | |
| vancomycin | Injection | 500 mg | |
| vancomycin | Powder for injection | 1 g |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| sulfamethoxazole + trimethoprim | Injection | 80 mg/ 16 mg/ml | |
| sulfamethoxazole + trimethoprim | Oral liquid | 200 mg + 40 mg/5 mL | |
| sulfamethoxazole + trimethoprim | Tablet | 400 mg + 80 mg | |
| sulfamethoxazole + trimethoprim | Tablet | 800 mg + 160 mg | |
| trimethoprim | Tablet | 200 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ethambutol | Tablet | 400mg | |
| isoniazid | Tablet | 100mg | |
| pyrazinamide | Tablet | 500 mg | |
| rifampicin | Capsule | 150 mg | |
| rifampicin | Syrup | 100 mg/5 ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| metronidazole | Injection | 5 mg/mL | |
| metronidazole | Suppository | 500 mg | |
| metronidazole | Suspension | 200 mg/ 5 ml | |
| metronidazole | Tablet | 250 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ciprofloxacin | Injection | 2mg (lactate)/ml | |
| ciprofloxacin | Tablet | 250 mg | |
| levofloxacin | Injection | 5 mg/ ml | |
| levofloxacin | Tablet | 500 mg | |
| norfloxacin | Tablet | 400 mg | |
| ofloxacin | Tablet | 200 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| nitrofurantoin | Capsule | 100 mg | |
| nitrofurantoin | Capsule | 50 mg | |
| nitrofurantoin | Oral liquid | 25 mg/5 ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amphotericin B | Injection | 50 mg | |
| fluconazole | Capsule | 150 mg | |
| fluconazole | Capsule | 50 mg | |
| fluconazole | Injection | 2 mg/mL in vial | |
| griseofulvin | Oral liquid | 125 mg/5 ml | |
| griseofulvin | Tablet | 125 mg | |
| griseofulvin | Tablet | 500mg | |
| itraconazole | Capsule | 100 mg | |
| ketoconazole | Suspension | 100 mg/5mL | |
| ketoconazole | Tablet | 200 mg | |
| miconazole | Gel | 2% (20 mg/ g) | |
| nystatin | Oral liquid | 100 000 IU/ml | |
| terbinafine | Tablet | 250mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| didanosine (ddI) | Tablet | 400 mg | |
| lamivudine (3TC) | Oral liquid | 10mg/ml | |
| lamivudine (3TC) | Tablet | 150 mg | |
| stavudine (d4T) | Capsule | 30 mg | |
| stavudine (d4T) | Capsule | 40 mg | |
| tenofovir | Tablet | 300 mg | |
| zidovudine (ZDV or AZT) | Capsule | 100 mg | |
| zidovudine (ZDV or AZT) | Injection | 10 mg/mL | |
| zidovudine (ZDV or AZT) | Syrup | 50 mg/ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| efavirenz (EFV or EFZ) | Tablet | 600 mg | |
| nevirapine (NVP) | Tablet | 200 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| darunavir | Tablet | 300 mg | |
| indinavir (IDV) | Capsule | 400mg | |
| lopinavir + ritonavir (LPV/r) | Tablet | 200 mg/ 50 mg | |
| nelfinavir | Tablet | 250 mg | |
| nelfinavir | Tablet | 625 mg | |
| ritonavir | Capsule | 100 mg | |
| ritonavir | Oral liquid | 80 mg/ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| Acyclovir | Capsule | 200 mg | |
| Acyclovir | Cream | 5% | |
| Acyclovir | Powder for injection | 500 mg | |
| Acyclovir | Suspension | 200 mg/ 5ml | |
| valacyclovir | Tablet | 500mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| chloroquine | Injection | 40 mg/ml | |
| chloroquine | Syrup | 50 mg/ml | |
| chloroquine | Tablet | 150 mg | |
| hydroxychloroquine | Tablet | 200 mg | |
| mefloquine | Tablet | 250 mg | |
| primaquine | Tablet | 15 mg | |
| proguanil | Tablet | 100 mg (as hydrochloride) | |
| quinine | Injection | 300 mg quinine hydrochloride/mL in 2-mL ampoule | |
| quinine | Tablet | 300 mg (bisulphate or sulphate) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| pyrimethamine | Tablet | 25 mg | |
| sulfadiazine | Tablet | 500 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| albendazole | Oral liquid | 100mg/5ml | |
| mebendazole | Tablet | 100 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| Insulin | Injection | -Aspart 3ml | |
| insulin soluble | N/A | 100 units/ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| insulin 70/30 | Injection | 100 UI/ ml | |
| insulin glargine | Injection | 100 UI/ml | |
| insulin pen 70/30 | Penfill cartridge | 100 mg/mL, 3 mL | |
| NPH insulin (intermediate-acting insulin) | Injection | 100 IU/mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| chlorpropramide | Tablet | 250 mg | |
| glibenclamide | Tablet | 5 mg | |
| gliclazide | Tablet | 80 mg | |
| Tolazamide | Tablet | 250 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| metformin | Tablet | 500 mg (hydrochloride) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acarbose | Tablet | 50 mg | |
| Nateglinide | Tablet | 120 mg | |
| rosiglitazona | Tablet | 4 mg | |
| sitagliptin | Tablet | 100 mg | |
| sitagliptin | Tablet | 25 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| levothyroxine | Tablet | 100 mcg (sodium salt) | |
| levothyroxine | Tablet | 25 mcg (sodium salt) | |
| levothyroxine | Tablet | 50 mcg (sodium salt) | |
| liothyronine | Tablet | 25mcg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| carbimazole | Tablet | 5 mg | |
| iodine | Solution | 130 mg/ml | |
| propylthiouracil | Tablet | 50 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| fludrocortisone | Tablet | 100 mcg (acetate) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| dexamethasone | Injection | 4 mg/mL | |
| dexamethasone | Tablet | 0.5 mg | |
| dexamethasone | Tablet | 2 mg | |
| dexamethasone | Tablet | 4 mg | |
| hydrocortisone | Injection | 250 mg (as sodium succinate) | |
| hydrocortisone | Powder for injection | 100 mg (as sodium succinate) in vial | |
| hydrocortisone | Tablet | 10 mg | |
| methylprednisolone | Injection | 40 mg (acetate)/mL | |
| methylprednisolone | Injection | 40 mg/mL (as sodium succinate) in 1-mL single dose vial | |
| methylprednisolone | Injection | 500 mg (sodium succinate) | |
| prednisolone | Tablet | 1 mg. | |
| prednisolone | Tablet | 20 mg | |
| prednisolone | Tablet | 5 mg | |
| prednisolone | Tablet soluble | 5 mg | |
| triamcinolone | Injection | 40 mg/ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| conjugated estrogens | Powder for injection | 25 mg | |
| conjugated estrogens | Tablet | 0.3 mg | |
| conjugated estrogens | Tablet | 0.625 mg | |
| conjugated estrogens | Tablet | 0.625 mg | |
| conjugated estrogens | Tablet | 1.25 mg | |
| conjugated estrogens | Tablet | 1.25 mg | |
| estradiol | Gel | 0.1% | |
| estradiol | implant | 50 mg | |
| estradiol | Patch | 100 mcg | |
| estradiol | Patch | 25 mcg | |
| estradiol | Patch | 50 mcg | |
| estradiol | Tablet | (Estradiol 2mg & Norethisterone Acetate 1mg) tablets | |
| estradiol | Tablet | (Estradiol Valerate 2mg tablets x 11/Estradiol Valerate 2mg + Levonorgestrel 250mcg (=norgestrol 500mcg) tablets x 10) | |
| estradiol | Tablet | -(Estradiol Valerate 2mg tablets x 16/Estradiol Valerate 2mg + Norethisterone 1mg tablets x12) | |
| estradiol | Tablet | 1 mg | |
| estradiol | Tablet | 1 mg | |
| estradiol | Tablet | 2 mg | |
| estradiol | Tablet | 2 mg | |
| tibolona | Tablet | 2.5 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| medroxyprogesterone | Tablet | 5 mg | |
| medroxyprogesterone acetate | Tablet | 10 mg | |
| megestrol | Tablet | 20 mg | |
| norethisterone | Tablet | 5mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| clomiphene citrate | Tablet | 50 mg | |
| corticotrophin | N/A | N/A | |
| tetracosactide | Injection | 250 mcg/ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| desmopressin | Nasal spray | 10 mcg | |
| desmopressin | Solution for injection | 4 mcg/ml (acetate) | |
| vasopressin | Injection | 20 U/ ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| calcitonina | Injection | 200 unit/ml | |
| calcitonina | Nasal spray | 200 UI/ dose |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| alendronic acid | Tablet | 70 mg | |
| alendronic acid + colecalciferol | Tablet | 70mg/ 70mcg | |
| etidronate | Tablet | 200 mg (etidronate sodium) | |
| zoledronic acid | Injection | 800 mcg/ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| bromocriptine mesylate | Tablet | 2.5 mg | |
| cabergoline | Tablet | 500 mcg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| danazol | Capsule | 100 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| carboprost | Injection | 250 mcg/mL | |
| dinoprostone | Vaginal gel | 1 mg | |
| dinoprostone | Vaginal gel | 2 mg | |
| Gemeprost | Pessary | 1 mg | |
| methylergometrine | Injection | 200 mcg/ml | |
| methylergometrine | Tablet | 200 mg | |
| misoprostol | Tablet | 200 mcg | |
| oxytocin | Injection | 10 units/ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| alprostadil | Injection | 500 mcg | |
| indomethacin | Injection | 1 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| salbutamol | Injection | 0.5 mg/mL | |
| salbutamol | Injection | 1 mg/ mL - 5 mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| estradiol | Vaginal cream | 0.01% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| clotrimazole | Vaginal cream | 1% | |
| clotrimazole | Vaginal tablet | 500 mg | |
| ketoconazole | Cream | 2% | |
| miconazole | Cream | 1 % | |
| miconazole | Cream | 2% (nitrate) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetic acid | Vaginal gel | 0.92 % | |
| clindamycin | Vaginal cream | 2% | |
| metronidazole | Gel | 0.75% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| cyproterone + ethinyloestradiol | Tablet | 2 mg/ 35 mcg | |
| ethinylestradiol + levonorgestrel | Tablet | 3-phase 30microg + 50microg/ 40microg + 75microg/ 30microg + 125microg | |
| ethinylestradiol + levonorgestrel | Tablet | 30 mcg + 150 mcg | |
| ethinylestradiol + norethisterone | Tablet | 35 micrograms + 1 mg | |
| norelgestromina + etinilestradiol | Patch | 150 mcg/ 20 mcg/ 24 hrs | |
| noresthisterone + ethylestradiol | Tablet | 1 mg/ 20 mcg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| desogestrel | Tablet | 0.075 mg | |
| levonorgestrel | Tablet | 30 micrograms |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| medroxyprogesterone | Powder for injection | 150 mg in vial | |
| norethisterone enantate | Injection | 200 mg in 1-mL ampoule |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| levonorgestrel | Tablet | 1.5 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| doxazosina | Tablet | 4 mg | |
| prazosin | Tablet | 1mg | |
| tamsulosin | Capsule (delayed release) | 400 mcg | |
| terazosin | Tablet | 1 mg | |
| terazosin | Tablet | 2 mg | |
| terazosin | Tablet | 5 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| oxybutynin | Tablet | 5 mg | |
| tolterodine L- tartrate | Tablet | 2 mg | |
| tolterodine L- tartrate | Tablet (controlled release) | 4 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| sodium citrate | Liquid | (with citric acid) 1ml contains 1mmol each of Sodium and Bicarbonate |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| sodium chloride | Parenteral formulation | 0.9% (100 mL) | |
| sodium chloride | Solution | 0.9% 500 ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| phenylephrine | Injection | 1% | |
| sildenafil | Tablet | 100 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| indigo carmine dye | Injection | 10 ml | |
| potassium aminobenzoate | Tablet | 500 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| chlorambucil | Tablet | 2 mg | |
| cyclophosphamide | Powder for injection | 1000 mg | |
| cyclophosphamide | Powder for injection | 500 mg in vial | |
| cyclophosphamide | Tablet | 50 mg | |
| melphalan | Tablet | 2 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| bleomycin | Injection | 15 IU | |
| doxorubicin | Injection | 50 mg/25 mL (liposomal and non-liposomal) | |
| doxorubicin | Powder for injection | 10 mg in vial | |
| mitomycin | Injection | 2 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| capecitabine | Tablet | 500 mg | |
| cytarabine | Injection | 100 mg/mL | |
| epirubicin | Injection | 10 mg (powder for reconstitution) | |
| epirubicin | Injection | 50 mg (powder for injection) | |
| fludarabine | Injection | 50 mg (phosphate) | |
| fluorouracil | Cream | 5% | |
| fluorouracil | Injection | 10% | |
| gemcitabine | Injection | 1g | |
| gemcitabine | Injection | 200mg | |
| mercaptopurine | Tablet | 50 mg | |
| methotrexate | Injection | 100 mg/4 mL | |
| methotrexate | Injection | 50 mg/2ml | |
| methotrexate | Tablet | 2.5 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| etoposide | Capsule | 50 mg | |
| etoposide | Injection | 100 mg | |
| vinblastine | Injection | 1 mg/ml x 10 ml | |
| vincristine | Injection | 2 mg/mL x 10 mL | |
| vinorelbine | Injection | 50 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| bevacizumab | Injection | 100 mg/ 4 ml | |
| bevacizumab | Injection | 400 mg/ 16 ml | |
| cetuximab | Solution for injection | 100 mg | |
| dacarbazine | Powder for injection | 100 mg in vial | |
| dacarbazine | Powder for injection | 200 mg | |
| hydroxycarbamide | Solid oral dosage form | 500 mg | |
| temozolomide | Capsule | 100 MG |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| calcium folinate | Injection | 100 mg | |
| calcium folinate | Injection | 50 mg | |
| calcium folinate | Tablet | 5 mg | |
| mesna | Injection | 100 mg/ml in 10-ml ampoules |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| trastuzumab | Powder for injection | 440 mg in vial | |
| trastuzumab | Powder for injection | 440 mg in vial |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| carboplatin | Injection | 150 mg/15 mL | |
| carboplatin | Injection | 600 mg/60 mL | |
| cisplatin | Injection | 100 mg/100 mL | |
| cisplatin | Injection | 50 mg/ 50 ml | |
| oxaliplatin | Powder for injection | 100 mg in vial | |
| oxaliplatin | Powder for injection | 50 mg in vial |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| docetaxel | Injection | 40 mg/ml (2 ml) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| irinotecan | Injection | 2 mg/mL x 2 mL | |
| irinotecan | Injection | 2 mg/mL x 5 mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| azathioprine | Tablet | 50 mg | |
| mycophenolate mofetil | Tablet | 250 mg | |
| mycophenolate mofetil | Tablet | 500 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ciclosporin | Capsule | 100 mg | |
| ciclosporin | Capsule | 25 mg | |
| ciclosporin | drops | 0.05% | |
| ciclosporin | Solution | 100 mg/ml | |
| tacrolimus | Capsule | 0.5 mg | |
| tacrolimus | Capsule | 1 mg | |
| tacrolimus | Capsule | 5 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| BCG for immunotherapy | Suspension | 81 mg/ 3 ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ferrous fumarate | Oral liquid | 28 mg/mL | |
| ferrous fumarate + folic acid | Tablet | 322 mg (105 mg iron), folic acid 350 micrograms | |
| ferrous sulfate | Oral solution (drops) | 125 mg/ ml | |
| ferrous sulfate | Tablet | 200mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| iron sucrose | Injection | 100 mg/ 5 ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| folic acid | Oral liquid | 2.5 mg/ 5 mL | |
| folic acid | Tablet | 0.4 mg | |
| folic acid | Tablet | 5 mg | |
| hydroxocobalamin | Injection | 1 mg/mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| epoetin alpha | Solution for injection | 10 000 UI | |
| epoetin alpha | Solution for injection | 2 000 IU | |
| epoetin alpha | Solution for injection | 3 000 UI | |
| epoetin alpha | Solution for injection | 4 000 IU |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| anagrelide | Capsule | 500 mcg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| filgrastim | Injection | 300 micrograms/mL in 1 mL vial |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| desferrioxamine mesilate | Injection | 500 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| potassium chloride | Tablet | 600 mg | |
| potassium chloride | Tablet (effervescent) | 470 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| oral rehydration salts | Powder for solution | 250 mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| sodium bicarbonate | Tablet | 650 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| calcium polystyrene sulphonate | Powder | 300 g |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| dextrose | Injection | 10% in 500ml | |
| dextrose | Solution for injection | 5% - 100mL | |
| dextrose | Solution for injection | 5% - 250 mL | |
| dextrose | Solution for injection | 5% - 500 mL. | |
| dextrose | Solution for injection | 50% - 50 mL | |
| glucose with sodium chloride | Injectable solution | glucose 5%, sodium chloride 0.2% | |
| glucose with sodium chloride | injection for intravenous administration | 5% glucose + 0.45% sodium chloride (500 mL) | |
| glucose with sodium chloride | injection for intravenous administration | 5% glucose + 0.9% sodium chloride (500 mL) | |
| potassium chloride | Injection | 20 mEq/ 100 ml | |
| ringer lactate solution | Parenteral formulation | 500ml | |
| sodium bicarbonate | Injection | 8.4% | |
| sodium chloride | Injectable solution | 0.9% (9 mg/mL)-10 mL | |
| sodium chloride | Injection | 23.4% 30 ml | |
| sodium chloride | Parenteral formulation | 0.45% (500mL) | |
| sodium chloride | Parenteral formulation | 0.9% (100 mL) | |
| sodium chloride | Parenteral formulation | 0.9% (20 mL) | |
| sodium chloride | Parenteral formulation | 0.9% (5 mL) | |
| sodium chloride | Solution | 3% x 500 ml | |
| water for injection | Liquid | 20 ml | |
| water for injection | N/A | 10-ml ampoules | |
| water for injection | N/A | 2-ml ampoules | |
| water for injection | N/A | 5-mL ampoules | |
| water for irrigation | Injection | 1000 ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| albumin | Injectable solution | 25%, 50 mL | |
| albumin | Injectable solution | 5%, 50 mL | |
| dextran 70 | Injectable solution | in 0.9% sodium chloride, 500 mL | |
| gelofusine | Solution for IV infusion | 500 mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| Amino Acid + Dextrose | Injection | 4.25% + 25% | |
| Amino Acid + Dextrose | Intravenous administration | 2.75% + 10% | |
| balanced electrolyte solution | Intravenous administration | premixed electrolyte solution- 20 mL | |
| lipid emulsion | Intravenous administration | 10%, 500 mL | |
| lipid emulsion | Intravenous administration | 30%, 500 mL | |
| multivitamins | Intravenous administration | fat soluble vitamins- 10 mL | |
| multivitamins | Intravenous administration | water soluble vitamins- 10 mL | |
| sodium chloride | Injection | 23.4% 30 ml | |
| Sodium Phosphate | Injection | 3 mmol/4mEQ | |
| trace elements (oligoelementos) | Intravenous administration | (or Additrace), 10 mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| calcium | Tablet (effervescent) | 1000 mg | |
| calcium chloride | Injection | 10% in 10-mL vial | |
| calcium gluconate | Injection | 100 mg/mL in 10-mL ampoule |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| cinacalcet | Tablet | 30 mg | |
| cinacalcet | Tablet | 60 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| magnesium oxide | Tablet | 500 mg | |
| magnesium sulfate | Injection | 50% x 2 ml | |
| magnesium sulfate | Injection | 50% x 50 ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| calcium acetate | Tablet | 667 mg | |
| sevelamer carbonate | Tablet | 800 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| fluoride sodium and polyvitamin | Tablet | containing 1mg of Elemental Fluoride |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| zinc sulfate | Tablet | 220 mg (50 mg elemental zinc) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| retinol | Solid oral dosage form | 5000 IU |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| pyridoxine | Tablet | 50 mg | |
| thiamine | Tablet | 50 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ascorbic acid | Tablet | 500 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| alfacalcidol | Tablet | 0.25 mcg | |
| ergocalciferol | Capsule | 1.25 mg | |
| paricalcitol | Solution for injection | 5 mcg/ ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| menadiol sodium phosphate | Tablet | 10 mg | |
| phytomenadione | Injection | 10 mg/mL in 1-mL vial | |
| phytomenadione | Injection | 10 mg/mL; 0.2 mL | |
| phytomenadione | Tablet | 10 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| multivitamin/ mineral | N/A | N/A | |
| multivitamins | drops | with fluride ( (0.25mg Fluoride in 1ml & 0.5mg Fluoride/1ml)) | |
| multivitamins | Tablet (chewable) | N/A | |
| multivitamins | Tablet (chewable) | with fluoride (1mg Fluoride per tablet) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| multivitamin/ mineral | Syrup | N/A | |
| multivitamins | Tablet | Renal vitamins | |
| vitamin B + C | Injection | High potency |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetylsalicylic acid | Tablet | 300 mg | |
| acetylsalicylic acid | Tablet | 75 mg | |
| acetylsalicylic acid | Tablet | 81mg | |
| celecoxib | Capsule | 100 mg | |
| diclofenac | drops | 1.5% | |
| diclofenac | Injection | 25 mg (sodium)/mL | |
| diclofenac | Suppository | 100 mg | |
| diclofenac | Suppository | 12.5 mg | |
| diclofenac | Suppository | 50 mg | |
| diclofenac | Tablet | 25 mg | |
| diclofenac (sodium) | Tablet | 100 mg | |
| diclofenac (sodium) | Tablet | 50mg | |
| etoricoxib | Tablet | 30 mg | |
| ibuprofen | Suspension | 100 mg/5 mL | |
| ibuprofen | Tablet | 200 mg | |
| ibuprofen | Tablet | 400 mg | |
| ibuprofen | Tablet | 600 mg | |
| indomethacin | Capsule | 25 mg | |
| indomethacin | Injection | 1 mg | |
| mefenamic acid EC | Capsule | 250 mg | |
| meloxicam | Tablet | 7.5 mg | |
| naproxen | Tablet | 250 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| dexamethasone | Injection | 4 mg/mL | |
| methylprednisolone | Injection | 40 mg (acetate)/mL | |
| methylprednisolone | Injection | 40 mg/mL (as sodium succinate) in 1-mL single dose vial | |
| triamcinolone | Injection | 40 mg (acetonide)/mL in 1-mL vial |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| chloroquine | Oral liquid | 50 mg (as phosphate or sulfate)/5 ml | |
| chloroquine | Tablet | 250mg (150mg base) as phosphate | |
| hydroxychloroquine | Tablet | 200 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| azathioprine | Tablet | 50 mg | |
| ciclosporin | Capsule | 100 mg | |
| ciclosporin | Capsule | 25 mg | |
| ciclosporin | Solution | 100 mg/ml | |
| methotrexate | Tablet | 2.5 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| allopurinol | Tablet | 100 mg | |
| allopurinol | Tablet | 300 mg | |
| colchicine | Tablet | 0.5mg | |
| probenecid | Tablet | 500 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| edrophonium chloride | Injection | 10 mg/ml | |
| neostigmine | Injection | 2.5 mg/ml | |
| pyridostigmine | Tablet | 60 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| baclofen | Tablet | 10 mg | |
| dantrolene | Capsule | 25 mg | |
| diazepam | Injection | 10 mg in 2-mL ampoule | |
| diazepam | Oral liquid | 2 mg/5 mL | |
| diazepam | Tablet | 2 mg | |
| diazepam | Tablet | 5 mg | |
| orfenadrine | Injection | 30mg (citrate)/ml in 2ml vial | |
| orfenadrine | Tablet | 50 mg | |
| Tizanidine hydrochloride | Tablet | 2 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| quinine | Tablet | 300 mg (quinine sulfate) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| hyaluronidase | Powder for injection | 1500 units |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| diclofenac | Gel | 1% | |
| methylsalicylate | Ointment | with menthol |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| Hylan G-F 20 | Injection | 2 mL (intra-articular) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| chloramphenicol | Eye ointment | 1% | |
| chloramphenicol | Solution (eye drops) | 0.5% | |
| Chloranfenicol | N/A | 0.5% Minims – 20 x 0.5ml | |
| ciprofloxacin | Eye ointment | 0.3% | |
| erythromycin | Eye ointment | 0.5% | |
| gentamicin | Eye ointment | 1 % | |
| neomycin + polymyxin B + bacitracina | drops | (Neomycin Sulphate 1700u, Polymyxin B Sulphate 5000u, Gramicidin 25u/ml) | |
| neomycin + polymyxin B + bacitracina | Ointment | N/A | |
| tetracycline | Eye ointment | 1 % | |
| tobramycin | dro | 0.3% x 5 ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| natamycin | Solution (eye drops) | 5% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| Acyclovir | eye drops | 3 % |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| betamethasone | eye drops | 0.1% | |
| betamethasone sodium phosphate + neomycin sulphate | eye drops | 0.1%/ 0.5% | |
| dexamethasone/neomycin/ polymixin B | Eye ointment | N/A | |
| prednisolone | eye drops | -preservative free Minims- 20 x 0.5ml | |
| prednisolone | Solution (eye drops) | 0.5% (sodium phosphate) | |
| prednisolone | Solution (eye drops) | 1% (acetate) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| Antazoline sulphate /Xylometazoline hydrochloride | eye drops | 0.05% | |
| cromoglycate | Solution (eye drops) | 2% (sodium) | |
| nepafenac | Solution (eye drops) | 0.1%; 3 mL | |
| olopatadine hcl | Solution (eye drops) | 0.2% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| atropine | Eye ointment | 1 % | |
| atropine | Solution | 0.5mL X 20 (minims) | |
| atropine | Solution | 1%, 15 mL | |
| cyclopentolate | Solution | 0.5% (minims) | |
| cyclopentolate | Solution (eye drops) | 1% (minims) | |
| cyclopentolate | Solution (eye drops) | 1%, 5mL | |
| homatropine | Solution (eye drops) | 2% | |
| phenylephrine | Solution (eye drops) | 10% | |
| tropicamide | Solution (eye drops) | 1% (0.5mL x 20-minims) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetazolamide | Injection | 500 mg | |
| acetazolamide | Tablet | 250 mg | |
| acetazolamide | Tablet (controlled release) | 250 mg | |
| dorzolamide | Solution (eye drops) | 2% | |
| dorzolamide + timolol | eye drops | 2%/ 0.5% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| pilocarpine | eye drops | 1 % (Nitrate) | |
| pilocarpine | Solution (eye drops) | 2% (hydrochloride) | |
| pilocarpine | Solution (eye drops) | 4% (hydrochloride or nitrate) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| bimatoprost | Solution (eye drops) | 0.3 mg/ ml | |
| latanoprost | Solution (eye drops) | 0.005% | |
| latanoprost + timolol | Solution (eye drops) | 0.005%/ 0.5% | |
| travoprost | Solution | 0.004% x 2.5 ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| brimonidine | Solution (eye drops) | 0.15%, 10 mLs |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| proxymetacaine | Solution (eye drops) | 0.5% | |
| tetracaine | Solution (eye drops) | 0.5% (hydrochloride) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetylcysteine | Solution (eye drops) | 5%, 10 mLs | |
| carbomer | Eye gel | 10g | |
| ciclosporin | Solution (eye drops) | 0.05%, 1mL x 32 | |
| goniosol | Solution (eye drops) | 2.5%, 15mLs | |
| hypromellose | Solution (eye drops) | 15 mLs | |
| paraffin | Eye ointment | 10 mL | |
| sodium chloride | Solution (eye drops) | 0.9%, 0.5 mL x 20 (minims) | |
| sodium chloride | Solution (eye drops) | 0.9%, 10mL | |
| sodium chloride hypertonic | Eye ointment | 5% | |
| sodium chloride hypertonic | Solution (eye drops) | 5% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| fluorescein | Injection | 1%, 0.5 mL | |
| fluorescein | strips | 1 mg | |
| fluorescein | strips | 2% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| balanced salt | Solution | 15 mL | |
| balanced salt | Solution | 500 ml | |
| hyaluronate sodium | Injection | 10 mg/ml | |
| phenol | Injection | in water 6.67% | |
| polyvinyl alcohol | Solution (eye drops) | 1.4%, 30 x 0.4 ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetic acid | ear drops | 2%, 15 mLs | |
| betamethasone | ear drops | 0.1%, 10 mLs | |
| betamethasone sodium phosphate + neomycin sulphate | ear drops | 0.1%, 0.5%- 10 mLs | |
| ciprofloxacin | Topical | 0.3% drops (as hydrochloride) | |
| clotrimazole | Solution | 1% | |
| dexamethasone/ framycetin/ gramicidin | Solution (eye drops) | 0.05%/ 0.5%/ 0.005% | |
| gentamicin | Ointment | ear/ eye 0.3% | |
| neomycin + polymyxin B + bacitracina | drops | (Neomycin Sulphate 1700u, Polymyxin B Sulphate 5000u, Gramicidin 25u/ml) | |
| tetracycline | Eye ointment | 1 % | |
| tobramycin | drops | 0.3% (ear/eye) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| almond/arachis oil | ear drops | with rectified camphor oil- 10 ml | |
| docusate sodium | ear drops | 0.5%, 10 ml | |
| olive oil | ear drops | 10 ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| levocabastina | Nasal spray | 0.05%, 10 ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| beclometasone | Nasal spray | 200 metered doses | |
| betamethasone sodium phosphate + neomycin sulphate | nose drops | 0.1%/ 0.5% | |
| cromoglycate | Nasal spray | 20 mg (sodium)/ml | |
| fluticasone | Metered dose inhaler (aerosol) | 50 mcg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ipratropium bromide | Nasal spray | 0.03%, 180 doses |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| normal saline | nose drops | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ephedrine | Nasal drops | 0.5% | |
| ephedrine | Nasal drops | 1% | |
| xylometazoline | Nasal drops | 0.05% | |
| xylometazoline | Nasal drops | 1% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| betamethasone sodium phosphate + neomycin sulphate | nose drops | 0.1%/ 0.5% | |
| chlorhexidine + neomycin | Cream | 0.1%+ 0.5% (nasal cream) | |
| mupirocin | Ointment | 2% (nasal ointment) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| carmellose | paste | (protective paste), 30g | |
| choline salicylate | Oromucosal administration | 8.7%, 15g | |
| triamcinolone | paste | (dental paste) 0.1%, 10 g |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| clotrimazole | Lozenge | 10 mg | |
| miconazole | Gel | (oral gel) 2%, 78g | |
| nystatin | Oral liquid | 100 000 IU/ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| benzalkonium chloride | Lozenge | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| chlorhexidine | Gel | dental gel 1%. 50 g | |
| chlorhexidine | mouth wash | 0.2% | |
| hydrogen peroxide | mouth wash | 3% solution, 16 oz | |
| iodine-povidone | mouth wash | 1%, 250 mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| artificial saliva | Aerosol | 50 ml | |
| carmellose | Solution | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| pilocarpine | Tablet | 5 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| aqueous | Cream | N/A | |
| emulsifying | Ointment | N/A | |
| paraffin | N/A | soft white 500 g |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| aqueous | Cream | N/A | |
| colloidal oatmeal | oil | bath 295 ml | |
| emollient mixture | Cream | 195 ml | |
| emulsifying | Ointment | 100 g | |
| emulsifying | Ointment | 500 g | |
| urea | Cream | 10% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| antiseptic healing mixture | Cream | 60 g | |
| zinc oxide | Ointment | with castor oil, 100 g | |
| zinc oxide | Powder | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| benzocaina | spray | 20%, 195 ml | |
| calamine | Lotion | N/A | |
| crotamiton | Lotion | 10% | |
| lignocaine HCI | Gel | 2%, non-sterile | |
| lignocaine HCI | Gel | 2%, sterile | |
| lignocaine HCI | Solution | 4% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| betamethasone | Cream | 0.1% (as valerate) | |
| betamethasone | Ointment | 0.1% (as valerate) | |
| betamethasone | Solution | (as valerate) 0.1% scalp application | |
| betamethasone + fusidic acid | Cream | 0.1%/ 2%, 15 g | |
| clobetasol | Cream | 0.05% | |
| desonide | Lotion | 0.05%, 60 ml | |
| hydrocortisone | Cream | 1% | |
| hydrocortisone | Lotion | 1% | |
| hydrocortisone | Ointment | 1% | |
| hydrocortisone + clotrimazole | Cream | 1%/ 1% | |
| hydrocortisone + crotamiton | Cream | 0.25%/ 10% | |
| hydrocortisone + fusidic acid | Cream | 1%/ 2% | |
| methylprednisolone | Cream | 1% (as aceponate) | |
| miconazole + betamethasone | Cream | 2%/0.1% | |
| mometasone | Cream | (as furoate) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| methotrexate | Tablet | 2.5 mg | |
| tacrolimus | Ointment | 0.03% | |
| tacrolimus | Ointment | 0.1% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| coal tar | Solution | 4% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| betamethasone + calcipotriol | Ointment | 0.5 mg/ 50 mcg x 30 g | |
| calcipotriol | Cream | 0.005% | |
| flumetasone + salicylic acid | Ointment | 0.2%/ 3%, 30 g |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| benzoyl peroxide + clindamycin | Gel | 5%/1% | |
| clindamycin | Solution | 1% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| cyproterone + ethinyloestradiol | Tablet | 2 mg/ 35 mcg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| isotretinoin | Capsule | 20 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| azelaic acid | Cream | 20% | |
| benzoyl peroxide | Gel | 10% | |
| benzoyl peroxide | Gel | 5% | |
| benzoyl peroxide + clindamycin | Gel | 5%/1% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| adapalene | Gel | 0.1% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| imiquimod | Cream | 5% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| formaldehyde | Solution | 37% | |
| salicylic acid | Patch | 40% | |
| salicylic acid + lactic acid | Solution | 16.7%/ 16.7% | |
| silver nitrate | stick | N/A | |
| trichloroacetic acid | Solution | 80% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ketoconazole | shampoo | 2% | |
| zinc pyrithione | shampoo | 1% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| fusidic acid | Cream | 2% | |
| gentamicin | Ointment | 0.1% | |
| metronidazole | Gel | 0.75% | |
| mupirocin | Ointment | 2% | |
| neomycin + bacitracin | Ointment | 5000 IU/250IU/ 5 mg | |
| neomycin + bacitracin | Powder | 5000 IU/ 250 IU/ 5mg | |
| silver sulfadiazine | Cream | 1% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amorolfine | Liquid | (nail lacquer) 5%, 5ml | |
| clotrimazole | Cream | 1% | |
| clotrimazole | Solution | 1% | |
| ketoconazole | Cream | 2% | |
| miconazole | Cream | 2% (nitrate) | |
| miconazole | Powder | 2 % (20 mg/ g) | |
| salicylic acid + benzoic acid + precipitated sulfur (Whitfield´s ointment with sulfur) | Ointment | 6% + 3% | |
| terbinafine | Cream | 1% | |
| terbinafine | spray | 1% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| aciclovir | Cream | 5% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| carbaryl | Liquid | 1% | |
| permethrin | shampoo | 1% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| collodion | N/A | Flexible, BP | |
| iodine-povidone | Ointment | 10% | |
| iodine-povidone | Solution | 10% | |
| magnesium sulfate | paste | 50 g | |
| mercurochrome | Solution | 2% | |
| tisseal fibrin sealant | N/A | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| chlorhexidine | Cream | 1% | |
| chlorhexidine | soap | 4% (as gluconate) | |
| chlorhexidine | Solution | 4% (as gluconate) | |
| chlorhexidine/ cetrimide | Solution | 30:1 | |
| gentian violet | Solution | 1% | |
| hydrogen peroxide | Solution | 3% | |
| iodine-povidone | Ointment | 10% | |
| iodine-povidone | Solution | 10% | |
| iodine-povidone | Solution | 7.5% | |
| potassium permanganate | Powder | N/A | |
| sodium chloride | Injectable solution | 0.9% (9 mg/mL)-10 mL | |
| sodium chloride | Solution | 0.9% 500 ml | |
| sterile solution for irrigation | Aqueous solution | F.E.U. - 500mL | |
| water for irrigation | Injection | 1 L |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| carmellose | Gel | (polymer, modified) 15 g | |
| dextranomer | pearls | N/A | |
| ichthammol compoud | N/A | as glycerin of ichthammol | |
| monsel's solution | N/A | N/A | |
| phenol | N/A | N/A | |
| silver nitrate | N/A | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetone | N/A | N/A | |
| alcohol | Solution | 70% (as isopropyl) | |
| chlorhexidine | Cream | 1% | |
| chlorhexidine | Solution | 1 in 200 alcoholic | |
| chlorhexidine | Solution | 1 in 200 aqueous | |
| chlorhexidine | Solution | 1 in 2000 aqueous | |
| chlorhexidine | Solution | 4% (as gluconate) | |
| chlorhexidine/ cetrimide | Solution | 30:1 | |
| formaldehyde | Solution | 37% | |
| glutaraldehyde | Solution | 2% | |
| hydrogen peroxide | Solution | 3% | |
| ortho-phthalaldehyde | Solution | N/A | |
| paracetic acid | N/A | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ethyl chloride (chloroethane) | spray | N/A | |
| lubricating jelly sterile | Sachet | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| BCG vaccine | Injection | N/A | |
| botulinum toxin A | Injection | 100 U in vial | |
| diptheria, tetanus, pertussis, haemophilus B | Injection | vaccine | |
| diptheria, tetanus, pertussis, poliomyelitis, haemophilus Influenza Type B | Injection | vaccine | |
| DT vaccine | Injection | N/A | |
| hepatitis A vaccine | N/A | N/A | |
| hepatitis B vaccine | Injection | N/A | |
| hepatitis B vaccine | Injection | pediatric | |
| human papilloma virus (HPV) vaccine | N/A | N/A | |
| influenza vaccine | N/A | N/A | |
| meningococcal meningitis vaccine | Injection | Meningococcal Polysaccharide A + C | |
| MMR vaccine | Injection | measles, mumps and rubella live virus | |
| pneumococcal vaccine | N/A | N/A | |
| poliomyelitis vaccine | Injection | N/A | |
| rabies vaccine | N/A | N/A | |
| rotavirus vaccine | N/A | N/A | |
| tetanus toxoid | N/A | N/A | |
| tuberculin, purified protein derivative (PPD) | Injection | N/A | |
| typhoid vaccine | Injection | N/A | |
| varicella-zoster | Injection | vaccine | |
| yellow fever vaccine | N/A | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| anti-D immunoglobulin (human) | Injection | 500 IU | |
| anti-hepatitis B immunoglobulin | N/A | N/A | |
| antitetanus immunoglobulin (human) | Injection | Norma PAI | |
| human normal immunoglobulin | Intravenous administration | 5% protein solution | |
| varicella-zoster | Injection | immune globulin 625units/ 6.25 ml | |
| varicella-zoster | Injection | immune globulin 125units/1.25ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| etomidate | Injection | 2 mg/ml x 10 ml | |
| ketamine | Injection | 50 mg (as hydrochloride)/mL in 10-mL vial | |
| propofol | Aqueous emulsion | 500 mg/ 50 ml | |
| propofol | Injection | 10 mg/ml x 20 ml | |
| thiopental | Injection | 0.5 g (as sodium) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| isoflurane | Solution | 100%/ 250 mL | |
| sevoflurane | N/A | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| atropine | Injection | 0.1mg/ml | |
| atropine | Injection | 0.6 mg/ml | |
| glycopyronium bromide | Injection | 0.2 mg/mL | |
| hyoscine hydrobromide | Injection | 400 mcg/mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| alfentanilo | Injection | 0.5 mg/ ml | |
| chlorpromazine | Injection | 25 mg (hydrochloride)/mL in 2-mL ampoule | |
| diazepam | Injection | 5 mg/mL | |
| diazepam | Oral liquid | 2.5 mg/5ml | |
| diazepam | Rectal solution | 2.5 mg | |
| diazepam | Rectal solution | 5 mg | |
| diazepam | Tablet | 2 mg | |
| diazepam | Tablet | 5 mg | |
| droperidol | Injection | 2.5mg/ml | |
| fentanyl | Injection | 50 mcg (citrate)/mL | |
| ketorolac | Injection | 30mg/ml | |
| lorazepam | Injection | 4 mg/ml | |
| lorazepam | Tablet | 1 mg | |
| midazolam | Injection | 5 mg/mL | |
| midazolam | Oral liquid | 2.5mg/ml, 5ml | |
| midazolam | Tablet | 7.5 mg | |
| morphine | Injection | 10 mg/ml | |
| nalbuphine hydrochloride | Solution for injection | 10 mg/ml | |
| pethidine | Injection | 100 mg in 2-mL ampoule | |
| pethidine | Injection | 50 mg/ml | |
| Temazepam | Syrup | 10 mg/ 5ml | |
| Temazepam | Tablet | 10 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| atracurium | Injection | 10 mg/mL (besylate) | |
| cisatracurium | Injection | 2 mg/ml | |
| mivacuronium | Injection | 2 mg/ml | |
| pancuronium | Injection | 4 mg/ 2ml | |
| rocuronium bromide | Injection | 10mg/ml | |
| suxamethonium | Injection | 50 mg (chloride)/ml in 2-ml ampoule | |
| vecuronium | Powder for injection | 10 mg (bromide)/mL in ampoule |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| edrophonium chloride | Injection | 10 mg/ml | |
| neostigmine | Injection | 2.5 mg/ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| doxapram | Injection | 20 mg/ml | |
| flumazenil | Injection | 100mcg/ml | |
| naloxone | Injection | 0.4 mg/mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| dantrolene | Powder for injection | 20 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amethocaine | spray | (oral spray) | |
| bupivacaine | Injection | 0.25% (hydrochloride) in vial | |
| bupivacaine | Injection | 0.5% (hydrochloride) in vial | |
| bupivacaine + glucose | Injection | 0.5%/ 80 mg/ml | |
| Bupivacaine Hydrocholoride + Adrenaline (Epinephrine) | Injection | 2.5 mg + 5mcg/ml | |
| Bupivacaine Hydrocholoride + Adrenaline (Epinephrine) | Injection | 5 mg + 5mcg/ml | |
| cocaine HCl | Solution | 10% | |
| lignocaine + prilocaine | Cream | 2.5%/ 2.5% | |
| lignocaine HCI | Gel | 2% | |
| lignocaine HCI | Injection | 1% | |
| lignocaine HCI | Injection | 2% | |
| lignocaine HCI | spray | 0.1% | |
| lignocaine HCI + adrenaline | Injection | 2%/ 1:200 000 | |
| prilocaine | Injection | 1%, 50ml | |
| ropivacaine | Injection | 10mg/ml, 20 ml | |
| tetracaine | Gel | 4% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetylcysteine | Injection | 200 mg/ml in 10-ml ampoule | |
| amyl nitrite | Inhalation | N/A | |
| atropine | Injection | 0.6 mg/ml | |
| benzatropine | Injection | 1 mg/ml, 2ml | |
| black widow spider antivenom | Injection | 2.5 ml | |
| calcium gluconate | Gel | 2.5% | |
| charcoal, activated | Suspension | 240 mL | |
| desferrioxamine mesilate | Injection | 500 mg | |
| diazepam | Injection | 5 mg/mL | |
| diazepam | Rectal solution | 2.5 mg | |
| dicobalt edetate (cobalt EDTA) | Injection | 300 mg in 20-mL ampoule | |
| digoxin (specific anti-body fragment) | Injection | 38 mg | |
| dimercaprol | Injection | 50 mg/ml | |
| flumazenil | Injection | 0.5mg/5ml | |
| glucagon | Powder for injection | 1 unit | |
| ipecac | Liquid | N/A | |
| lorazepam | Injection | 4 mg/ml | |
| methylene blue | Aqueous solution | 1% | |
| naloxone | Injection | 0.4 mg/mL | |
| physostigmine | Injection | 2 mg/2 mL | |
| pralidoxime | Injection | 1g | |
| sodium calcium edetate | Injection | 200 mg/ml in 5-ml ampoule | |
| sodium nitrate/Sodium Thiosulphate/Amyl nitrate | N/A | Cyanide antidote kit |